MicrobiologybioRxivPreprint
Multiple Sclerosis Drug Fingolimod Exhibits Antibacterial Activity through Bacterial Membrane Permeabilization
Antara Syam, Benjamin Rees, Sebastián Cardona Cuervo…·John S. Choy
This study reveals that fingolimod, a multiple sclerosis drug, disrupts bacterial membranes through permeabilization, providing insight into its off-target antimicrobial activity.
1 citation